Literature DB >> 11496236

Possible role of the 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene in the development of asthma.

S H Cho1, I P Hall, A Wheatley, J Dewar, D Abraha, J Del Mundo, H Lee, C K Oh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11496236     DOI： 10.1067/mai.2001.117260

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  20 in total

Review 1.  Importance of mast cells in the pathophysiology of asthma.

Authors:  Seong H Cho; Andrea J Anderson; Chad K Oh
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

Review 2.  Coagulation-dependent mechanisms and asthma.

Authors:  Michael A Matthay; John A Clements
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

3.  Cross-talk between human mast cells and bronchial epithelial cells in plasminogen activator inhibitor-1 production via transforming growth factor-β1.

Authors:  Seong H Cho; Sun H Lee; Atsushi Kato; Tetsuji Takabayashi; Marianna Kulka; Soon C Shin; Robert P Schleimer
Journal:  Am J Respir Cell Mol Biol       Date:  2015-01       Impact factor: 6.914

4.  Association of elevated plasminogen activator inhibitor 1 levels with diminished lung function in patients with asthma.

Authors:  Seong Cho; Joseph Kang; Christopher Lyttle; Kathleen Harris; Brendan Daley; Leslie Grammer; Pedro Avila; Rajesh Kumar; Robert Schleimer
Journal:  Ann Allergy Asthma Immunol       Date:  2011-01-26       Impact factor: 6.347

5.  Polymorphism 4G/5G of the plasminogen activator inhibitor 1 gene as a risk factor for the development of allergic rhinitis symptoms in patients with asthma.

Authors:  Marina Lampalo; Irena Jukic; Jasna Bingulac-Popovic; Ivona Marunica; Roberta Petlevski; Gordana Pavlisa; Sanja Popovic-Grle
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-03       Impact factor: 2.503

6.  Soy isoflavones reduce asthma exacerbation in asthmatic patients with high PAI-1-producing genotypes.

Authors:  Seong H Cho; Ara Jo; Thomas Casale; Su J Jeong; Seung-Jae Hong; Joong K Cho; Janet T Holbrook; Rajesh Kumar; Lewis J Smith
Journal:  J Allergy Clin Immunol       Date:  2019-01-29       Impact factor: 10.793

7.  Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids.

Authors:  Prescott G Woodruff; Homer A Boushey; Gregory M Dolganov; Chris S Barker; Yee Hwa Yang; Samantha Donnelly; Almut Ellwanger; Sukhvinder S Sidhu; Trang P Dao-Pick; Carlos Pantoja; David J Erle; Keith R Yamamoto; John V Fahy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-26       Impact factor: 11.205

8.  Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness.

Authors:  Scott S Wagers; Ryan J Norton; Lisa M Rinaldi; Jason H T Bates; Burton E Sobel; Charles G Irvin
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

9.  A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumonia.

Authors:  Kevin K Kim; Kevin R Flaherty; Qi Long; Noboru Hattori; Thomas H Sisson; Thomas V Colby; William D Travis; Fernando J Martinez; Susan Murray; Richard H Simon
Journal:  Mol Med       Date:  2003 Jan-Feb       Impact factor: 6.354

10.  A plasminogen activator inhibitor-1 inhibitor reduces airway remodeling in a murine model of chronic asthma.

Authors:  Sun H Lee; Mesut Eren; Douglas E Vaughan; Robert P Schleimer; Seong H Cho
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-09       Impact factor: 6.914
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.